Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Solid Tumor Cancer 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Burkitt Lymphoma 2Waldenstrom Macroglobulinemia 1Spinal Cord Neoplasms 1Solid Tumours 1Optic Nerve Glioma 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Promyelocytic, Acute 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Erythroblastic, Acute 1Leukemia, Biphenotypic, Acute 1Hodgkin Disease 1Familial ependymoma 1Dendritic Cell Sarcoma, Interdigitating 1Congenital Abnormalities 1Choroid Plexus Neoplasms 1Breast Neoplasms 1Blast Crisis 1Astrocytoma 1

Interventions

ispinesib 2trametinib 1irinotecan sucrosofate 1Vincristine 1Temozolomide 1SB 743921 1Interleukin-18 1Immunotherapy 1Imatinib Mesylate 1Exercise Therapy 1Docetaxel 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Solid Tumor Cancer × ispinesib × Clear all
NCT00119171 2008-10-16

Ispinesib In Combination With Capecitabine In Patients With Solid Tumors

GlaxoSmithKline

Phase 1 Completed
30 enrolled
Other solid neoplasm

Solid Tumor Cancer

NCT00169520 2008-10-16

SB-715992 In Combination With Docetaxel In Patients With Solid Tumors

GlaxoSmithKline

Phase 1 Completed
30 enrolled
Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡